嘉必优: 嘉必优生物技术（武汉）股份有限公司第四届监事会第八次会议决议公告

Group 1 - The company held its fourth supervisory board meeting on August 29, 2025, with all three supervisors present, and the meeting complied with legal and regulatory requirements [1][2] - The supervisory board approved the proposal to terminate the issuance of shares and cash payment for asset acquisition, as well as the related fundraising and transaction matters, citing the decision as prudent for the benefit of the company and its investors [1][2] - The board also approved the signing of a termination agreement with the transaction counterparties, with unanimous support from all supervisors [2]